Add Company
Join Now

NeuroSigma Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Medical

Industry

Estimated Revenue & Valuation

  • NeuroSigma's estimated annual revenue is currently $1.1M per year.(i)
  • NeuroSigma's estimated revenue per employee is $78,857

Employee Data

  • NeuroSigma has 14 Employees.(i)
  • NeuroSigma grew their employee count by 133% last year.

NeuroSigma's People

NameTitleEmail/Phone
1
President & CEOReveal Email/Phone
2
Chief Medical Officer and SVPReveal Email/Phone
3
CFOReveal Email/Phone
4
Chief Financial OfficerReveal Email/Phone
5
VP Financial PlanningReveal Email/Phone
6
VP Finance & OperationsReveal Email/Phone
7
Director EngineeringReveal Email/Phone
8
Operations ManagerReveal Email/Phone
9
Operations ManagerReveal Email/Phone
10
Dir Advanced MaterialsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$8.2M2780%N/AN/A
#2
$0.3M8-33%N/AN/A
#3
$1.7M68106%N/AN/A
#4
$4M2414%$26.1MN/A
#5
$1.7M40%$1.7MN/A
#6
$7.5M2921%N/AN/A
#7
$3.5M150%$37.9MN/A
#8
$1.1M14133%N/AN/A
#9
$1.1M650%N/AN/A
#10
$3.4M20-5%N/AN/A
Add Company

What Is NeuroSigma?

NeuroSigma, Inc. is a Los Angeles-based bioelectronics company commercializing external trigeminal nerve stimulation (eTNS) technology. NeuroSigma's Monarch eTNS® System is a bioelectronic medical device that uses external trigeminal nerve stimulation to treat neurological and neuropsychiatric disorders. In 2019, the Monarch eTNS System became the first-ever medical device cleared by FDA for treating pediatric ADHD. The new Monarch Pediatric Care Co-Pay Program is making eTNS therapy available to a substantially greater number of children diagnosed with ADHD.

keywords:N/A

N/A

Total Funding

14

Number of Employees

$1.1M

Revenue (est)

133%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.4M14N/AN/A
#2
$1.8M14N/AN/A
#3
$0.9M14N/AN/A
#4
$2.1M14N/AN/A
#5
$1.2M14N/AN/A